Drug Profile


Alternative Names: LG 32001

Latest Information Update: 12 Apr 2000

Price : $50

At a glance

  • Originator Guidotti
  • Class Antihypertensives; Cyclohexanecarboxylic acids; Hydroxylamines; Small molecules
  • Mechanism of Action ACE inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Heart failure; Hypertension; Postmyocardial infarction

Most Recent Events

  • 12 Apr 2000 Discontinued-Preclinical for Postmyocardial infarction in Italy (Unknown route)
  • 12 Apr 2000 Discontinued-II for Hypertension in Italy (IV)
  • 12 Apr 2000 Discontinued-II for Hypertension in Italy (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top